Northwest Biotherapeutics (NWBO) Exchange Rate Effect (2010 - 2026)
Northwest Biotherapeutics (NWBO) posted quarterly Exchange Rate Effect of $2.2 million for Q1 2026, up 234.43% year-over-year from $650369.6 in Q1 2025, and up 287.7% quarter-over-quarter from $561000.0 in Q4 2025.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 234.43% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $1.9 million (up 254.57% YoY), while the FY2025 annual figure was -$1.9 million, down 245.48% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $2.2 million, up from $561000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.7 million in Q3 2022, with the low at -$3.9 million in Q2 2025.
- The 5-year median for Exchange Rate Effect is $561000.0 (2025), against an average of $386352.9.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect jumped 1509.38% in 2022, then tumbled 22952.94% in 2025.
- Northwest Biotherapeutics' Exchange Rate Effect stood at -$2.8 million in 2022, then jumped by 63.95% to -$1.0 million in 2023, then soared by 451.78% to $3.6 million in 2024, then sank by 84.21% to $561000.0 in 2025, then soared by 287.7% to $2.2 million in 2026.
- Business Quant data shows NWBO's Exchange Rate Effect at $2.2 million in Q1 2026, $561000.0 in Q4 2025, and $3.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - | -1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.20 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 561,000.00 |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Mar 31, 2025 | -1.62 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | -635,000.00 |
| Mar 31, 2023 | -784,000.00 |
| Dec 31, 2022 | -2.80 Mn |
| Sep 30, 2022 | 4.70 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Mar 31, 2022 | 899,000.00 |
| Dec 31, 2021 | 462,000.00 |
| Sep 30, 2021 | 862,000.00 |